get with
the program

get with
the program

The financial assistance programs you need

Whatever your personal situation or needs, we've probably got a way to lend a helping hand. Learn about all the resources, support, and financial assistance options available to you.*

Free Trial Plus Program*
Receive your first 30-day supply of ELOCTATE immediately with a valid prescription from your healthcare provider. You may also be eligible to receive free factor for a limited period of time, while Patient Services addresses your factor access issue.
DOWNLOAD APPLICATION
Copay Program*
Whether you’re new to ELOCTATE or already on therapy, ELOCTATE offers a Copay Program to eligible patients that can cover up to $20,000 of co-payment or co-insurance costs associated with your prescription. Best of all, there are no income requirements or caps, so you can get started with your treatment right away.
DOWNLOAD APPLICATION
Factor Access Program*
Helps you access ELOCTATE, even if your insurance coverage is interrupted—for example, you are between jobs or changing insurers.
DOWNLOAD APPLICATION

*Not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DoD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance programs. Not valid where prohibited by law. Sanofi Genzyme reserves the right to modify or discontinue the programs at any time. Savings may vary depending on patients’ out-of-pocket costs.

one number. one contact. two thumbs up.

1-855-MYELOCTATE

(1-855-693-5628)

Available Monday-Friday,
8AM-8PM ET

Get informed. Stay informed.

Let's stay in touch. We'll occasionally send you important information on Hemophilia A and ELOCTATE. If you're new to ELOCTATE, we'll send you a Bluetooth® speaker so you can listen to patient stories, or if you're already on ELOCTATE, we'll send you this stylish cooler bag.

Bluetooth is a registered trademark of Bluetooth SIG, Inc.

Bluetooth is a registered trademark of Bluetooth SIG, Inc.

×

INDICATION ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

Important Safety Information and Indication 

IMPORTANT SAFETY INFORMATION

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

INDICATION

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

Important Safety Information and Indication 

IMPORTANT SAFETY INFORMATION

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly.

Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort.

If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk.

These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE.

INDICATION

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

Please see Full Prescribing Information

MANUFACTURED BY

Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078

Click here to learn more about Sanofi's commitment to fighting counterfeit drugs.